Khairy Jamaluddin says he is convinced with the medical evidence for CBD and that MOH is looking at prescription medicines, not self-medication or recreational use of marijuana.
IMR researchers find limited clinical evidence for hemp to treat multiple sclerosis, epilepsy, chronic pain, cancer, inflammation, or constipation, or to promote sleep, and skin and brain health.
Sativex, registered in Malaysia in 2014, is the only NPRA-approved treatment with marijuana components, but the mouth spray for MS symptoms was pulled from market in 2017 on commercial grounds.